INS and sarcopenia: The management of sarcopenia resides on physical activity. The concomitant presence of other conditions (e.g. older age, obesity) and potential lack of long-term compliance requires other approaches. The evaluation of multiple cross-talks between insulin sensitive tissues and different disease pathways might bring to light optimal target for individualized therapy.